FNY Managed Accounts’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-2,400
Closed -$23K 696
2017
Q3
$23K Buy
+2,400
New +$23K 0.03% 300